speb/financial-data huggingface dataset:
Financial ratios for KMR.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1209462500
Buffett classification: The Gruesome
Stock price: 0.037625
Shares outstanding: 88648620
Book value: 1209462500.0000002
P/B ratio: 0.0027577575389894264
Market cap (USD): 3335404.3274999997
Debt to equity: 0.0682525984338773
Current ratio: 5.891507327568709
Quick ratio: 3.6019770226931356
Buyback yield (%): 0
Retained earnings: 401836458.3333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMR.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1238561176.4705882
Buffett classification: The Gruesome
Stock price: 0.043835616438356165
Shares outstanding: 88648620
Book value: 1238561176.4705882
P/B ratio: 0.003137484831539016
Market cap (USD): 3885966.9041095893
Debt to equity: 0.12314098807249778
Current ratio: 6.162954733360893
Quick ratio: 2.9589189747829687
Buyback yield (%): 0
Retained earnings: 325411764.7058824
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LSF — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 596505
Buffett classification: The Gruesome
Stock price: 13.04
Shares outstanding: 11004348
Market cap (USD): 143496697.92
Buyback yield (%): 0.10621429078805106
Capitalized R&D asset: 1030127
Rule of 40 score: 0
Financial ratios for LSF — annual report dated 2022-12-31
Total revenue: 38517388
Gross profit: 5187267
Operating income: -23953331
Net income: -40337318
Capital expenditures: 1136542
Operating cash flow: -14312439
Depreciation & amortization: 1118071
Net tangible assets: 21086794
Owner earnings: -40355789
Return on net tangible assets (%): -191.37944345641162
Buffett classification: The Gruesome
Stock price: 0.84
Shares outstanding: 11004348
Book value: 22511012
P/B ratio: 0.4106280215212003
Market cap (USD): 9243652.32
Debt to equity: 0.006037978212618784
Current ratio: 3.694307573066504
Quick ratio: 2.92989904259813
COGS to revenue (%): 79.55140935309528
R&D to revenue (%): 1.1099844049653627
SG&A to revenue (%): 74.54571166663742
Free cash flow (dilution-adjusted): -16100598
Buyback yield (%): 0
Retained earnings: -96135032
Inventory turnover: 5.378877446320721
Receivables turnover: 25.77329339049522
Capitalized R&D asset: 1117722.09
ROCI (R&D-adjusted, %): -101.29455544606726
FCF margin (%): -41.800856278208684
Rule of 40 score: -41.800856278208684
Financial ratios for LSF — annual report dated 2023-12-31
Total revenue: 40598004
Gross profit: 10313277
Operating income: -10698986
Net income: -10163117
Capital expenditures: 109693
Operating cash flow: -10765881
Depreciation & amortization: 306176
Net tangible assets: 12195288
Owner earnings: -9966634
Return on net tangible assets (%): -81.72528602850544
Buffett classification: The Gruesome
Stock price: 0.91
Shares outstanding: 11004348
Book value: 13412619
P/B ratio: 0.746607107828829
Market cap (USD): 10013956.68
Debt to equity: 0.02852806003063235
Current ratio: 3.73381009364864
Quick ratio: 2.288820213625676
COGS to revenue (%): 58.8967896057156
R&D to revenue (%): 0.5412162627502574
SG&A to revenue (%): 51.75688686566955
Free cash flow (dilution-adjusted): -12002050
Buyback yield (%): 0.2738378133267499
Retained earnings: -106298149
Inventory turnover: 3.78184228885804
Receivables turnover: 39.70962037301491
Capitalized R&D asset: 846114.7000000001
ROCI (R&D-adjusted, %): -76.11335251848506
Rosenberg metric: 11.989628967785244
FCF margin (%): -29.56315290771438
Revenue growth (%): 5.40175777235985
Rule of 40 score: -24.161395135354528
Financial ratios for LSF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.96
Shares outstanding: 11004348
Market cap (USD): 54581566.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LSF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.88
Shares outstanding: 11004348
Market cap (USD): 86714262.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LSF — annual report dated 2024-12-31
Total revenue: 49696841
Gross profit: 17687581
Operating income: -2173092
Net income: -1820161
Capital expenditures: 24776
Operating cash flow: 865502
Depreciation & amortization: 270271
Net tangible assets: 12168643
Owner earnings: -1574666
Return on net tangible assets (%): -12.94035826344811
Buffett classification: The Gruesome
Stock price: 7.88
Shares outstanding: 11004348
Book value: 13196866
P/B ratio: 6.570822363430833
Market cap (USD): 86714262.24
Debt to equity: 0.018673372905354955
Current ratio: 3.0340469776183108
Quick ratio: 2.0249270856148542
COGS to revenue (%): 51.52753270575086
SG&A to revenue (%): 39.96365282050825
Free cash flow (dilution-adjusted): -797062
Buyback yield (%): 0.08179277337757582
Retained earnings: -108118310
Inventory turnover: 4.285298600526534
Receivables turnover: 28.19021550151993
Capitalized R&D asset: 288301.62
ROCI (R&D-adjusted, %): -17.53199704758592
Rosenberg metric: 33.561821020102585
FCF margin (%): -1.6038484216733213
Revenue growth (%): 22.412030404253372
Rule of 40 score: 20.808181982580052
Financial ratios for LSF — quarterly report dated 2025-03-31
Total revenue: 13542133
Gross profit: 4881540
Operating income: -218019
Net income: -156182
Capital expenditures: 72214
Operating cash flow: -1274744
Depreciation & amortization: 66521
Net tangible assets: 12347605
Owner earnings: -161875
Return on net tangible assets (%): -1.3109829801001895
Buffett classification: The Gruesome
Stock price: 6.15
Shares outstanding: 11004348
Book value: 13330773
P/B ratio: 5.076730374150096
Market cap (USD): 67676740.2
Debt to equity: 0.016834882718353993
Current ratio: 2.512685346450543
Quick ratio: 1.3302813055768983
COGS to revenue (%): 50.01146422059213
SG&A to revenue (%): 37.65698505545618
Free cash flow (dilution-adjusted): -1855368
Buyback yield (%): 0.028506101125715864
Retained earnings: -108274492
Inventory turnover: 0.7120105795185936
Receivables turnover: 5.84308271147096
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6211478600408047
FCF margin (%): -13.700707266720832
Rule of 40 score: -13.700707266720832
Financial ratios for LSF — quarterly report dated 2025-06-30
Total revenue: 13606963
Gross profit: 4781003
Operating income: -399477
Net income: -362178
Capital expenditures: 0
Operating cash flow: -2827622
Depreciation & amortization: 59376
Net tangible assets: 12425763
Owner earnings: -302802
Return on net tangible assets (%): -2.436888583823786
Buffett classification: The Gruesome
Stock price: 6.3
Shares outstanding: 11004348
Book value: 13373941
P/B ratio: 5.18376687918692
Market cap (USD): 69327392.39999999
Debt to equity: 0.015103850091756799
Current ratio: 2.761744303823664
Quick ratio: 1.1769416091626292
COGS to revenue (%): 52.98639380440735
SG&A to revenue (%): 38.072272262370376
Free cash flow (dilution-adjusted): -3243984
Buyback yield (%): 0
Retained earnings: -108636670
Inventory turnover: 0.653798577480262
Receivables turnover: 4.945215426555519
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.9660351234416837
FCF margin (%): -23.840617483857347
Revenue growth (%): 0.47872812946084636
Rule of 40 score: -23.3618893543965
Financial ratios for LSF — quarterly report dated 2025-09-30
Total revenue: 14734848
Gross profit: 4702182
Operating income: -995582
Net income: -975066
Capital expenditures: 0
Operating cash flow: 1248535
Depreciation & amortization: 60137
Net tangible assets: 12556243
Owner earnings: -914929
Return on net tangible assets (%): -7.286646172744507
Buffett classification: The Gruesome
Stock price: 5.58
Shares outstanding: 11004348
Book value: 12808343
P/B ratio: 4.7940831878096954
Market cap (USD): 61404261.84
Debt to equity: 0.013987133230270302
Current ratio: 3.0764815528472256
Quick ratio: 1.4073740104693546
COGS to revenue (%): 55.606138590639006
SG&A to revenue (%): 38.66863098961048
Free cash flow (dilution-adjusted): 809085
Buyback yield (%): 0
Retained earnings: -109611736
Inventory turnover: 0.8210794101521879
Receivables turnover: 7.427557505565055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.730187058224749
FCF margin (%): 5.490962648545815
Revenue growth (%): 8.289028198283482
Rule of 40 score: 13.779990846829296
Financial ratios for LSF — quarterly report dated 2025-12-31
Total revenue: 15620175
Gross profit: 4545859
Operating income: -1801022
Net income: -1758785
Capital expenditures: 0
Operating cash flow: 68415
Depreciation & amortization: 67685
Net tangible assets: 11255687
Owner earnings: -1691100
Return on net tangible assets (%): -15.024404996336518
Buffett classification: The Gruesome
Stock price: 2.22
Shares outstanding: 11004348
Book value: 11462787
P/B ratio: 2.13121403721451
Market cap (USD): 24429652.560000002
Debt to equity: 0.013598350907157221
Current ratio: 2.44419756834174
Quick ratio: 1.4346171409593789
COGS to revenue (%): 56.35509205242579
SG&A to revenue (%): 40.632585742477275
Free cash flow (dilution-adjusted): -455117
Buyback yield (%): 0
Retained earnings: -111370521
Inventory turnover: 1.1311453143718673
Receivables turnover: 4.0059896825122046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.648111037152992
FCF margin (%): -2.913648534667505
Revenue growth (%): 6.00838909230689
Rule of 40 score: 3.094740557639385
Financial ratios for LSF — annual report dated 2025-12-31
Total revenue: 57432436
Gross profit: 18910584
Operating income: -3414100
Net income: -3252211
Capital expenditures: 76455
Operating cash flow: -2785416
Depreciation & amortization: 253719
Net tangible assets: 11255687
Owner earnings: -3074947
Return on net tangible assets (%): -27.31905213782153
Buffett classification: The Gruesome
Stock price: 2.22
Shares outstanding: 11004348
Book value: 11462787
P/B ratio: 2.13121403721451
Market cap (USD): 24429652.560000002
Debt to equity: 0.013598350907157221
Current ratio: 2.44419756834174
Quick ratio: 1.4346171409593789
COGS to revenue (%): 53.93938366117711
SG&A to revenue (%): 38.871212079529414
Free cash flow (dilution-adjusted): -4745384
Buyback yield (%): 1.4418993439831382
Retained earnings: -111370521
Inventory turnover: 3.9807285089799516
Receivables turnover: 14.729268145686108
Capitalized R&D asset: 72508.59
ROCI (R&D-adjusted, %): -30.10994038047191
FCF margin (%): -8.26255045145569
Revenue growth (%): 15.565566833513621
Rule of 40 score: 7.3030163820579315
Financial ratios for MANORAMA.NS — annual report dated 2023-03-31
Total revenue: 42413507.91717418
Gross profit: 15930060.90133983
Operating income: 5554031.668696712
Net income: 3626735.6881851405
Capital expenditures: 6233580.9987819735
Operating cash flow: 7221023.142509135
Depreciation & amortization: 1321814.8599269185
Net tangible assets: 36248014.61632156
Owner earnings: -1285030.4506699145
Return on net tangible assets (%): -3.545105750678267
Capex to operating income (%): 112.23524406451075
Buffett classification: The Gruesome
Stock price: 2.4973203410475033
P/E ratio: 43.46521006095615
Shares outstanding: 63122390
Book value: 36334141.29110841
P/B ratio: 4.338531830422258
Market cap (USD): 157636828.5225335
Debt to equity: 0.3688199225419229
Current ratio: 2.815454229173915
Quick ratio: 1.1728637468724674
Effective tax rate (%): 30.85129853390958
Interest coverage ratio: 5.810293199454631
COGS to revenue (%): 62.441067283450536
R&D to revenue (%): 0.45256535547444976
SG&A to revenue (%): 7.0647752293195945
Free cash flow (dilution-adjusted): 943775.8830694276
Buyback yield (%): 0
Retained earnings: 15905651.644336177
Inventory turnover: 1.3788187501862803
Receivables turnover: 12.625218901486173
Capitalized R&D asset: 366813.2764760202
ROCI (R&D-adjusted, %): 13.860003279274505
FCF margin (%): 2.225177613020006
Rule of 40 score: 2.225177613020006
Financial ratios for MANORAMA.NS — annual report dated 2024-03-31
Total revenue: 54653831.39465164
Gross profit: 24127521.285525844
Operating income: 7184602.470320182
Net income: 4809773.354119199
Capital expenditures: 4682683.775032978
Operating cash flow: -18406907.303033937
Depreciation & amortization: 1631874.3254586882
Net tangible assets: 40328672.50269817
Owner earnings: 1758963.9045449095
Return on net tangible assets (%): 4.361571545473575
Capex to operating income (%): 65.17665792056403
Buffett classification: The Good
Stock price: 4.774352207293666
P/E ratio: 62.65753078948154
Shares outstanding: 63122390
Book value: 40413466.84254707
P/B ratio: 7.457131138991337
Market cap (USD): 301368522.02615166
Debt to equity: 1.0278218997240125
Current ratio: 1.6213987893090336
Quick ratio: 0.4862685410202713
Effective tax rate (%): 24.567296389983355
Interest coverage ratio: 3.2156854325785105
COGS to revenue (%): 55.853925205531084
R&D to revenue (%): 0.3979741016236018
SG&A to revenue (%): 8.134530956430194
Free cash flow (dilution-adjusted): -23209857.297038015
Buyback yield (%): 0
Retained earnings: 20180729.104209136
Inventory turnover: 0.6540053634015414
Receivables turnover: 10.897937858376016
Capitalized R&D asset: 432241.0775627129
ROCI (R&D-adjusted, %): 15.064790796556249
Rosenberg metric: 42.70648502707479
FCF margin (%): -42.467026930721836
Revenue growth (%): 28.85949330430429
Rule of 40 score: -13.607533626417545
Financial ratios for MANORAMA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 45030578.11753464
Buffett classification: The Gruesome
Stock price: 9.911610129001433
Shares outstanding: 63122390
Book value: 45115038.222646914
P/B ratio: 13.86775994742961
Market cap (USD): 625644520.0907788
Debt to equity: 0.9811251218218755
Current ratio: 1.691996410036813
Quick ratio: 0.6553903498370521
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANORAMA.NS — quarterly report dated 2024-12-31
Total revenue: 24385674.321016435
Gross profit: 12865287.329525584
Operating income: 5612647.161673854
Net income: 3551183.121575941
Capital expenditures: 0
Depreciation & amortization: 698997.5521622567
Owner earnings: 4250180.673738197
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.533978319151414
P/E ratio: 55.69796322992161
Shares outstanding: 63122390
Market cap (USD): 791174667.71302
Effective tax rate (%): 25.90365841201278
Interest coverage ratio: 4.400195560591799
COGS to revenue (%): 47.24243766989938
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANORAMA.NS — quarterly report dated 2025-03-31
Total revenue: 27216015.89899462
Gross profit: 13757341.594575636
Operating income: 6412169.745148468
Net income: 4681014.7299509
Capital expenditures: 0
Depreciation & amortization: 748398.4101005377
Net tangible assets: 53474772.03647416
Owner earnings: 5429413.140051438
Return on net tangible assets (%): 10.153223535666752
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.375423036527017
P/E ratio: 41.71992208913837
Shares outstanding: 63122390
Book value: 53743500.11690437
P/B ratio: 14.535083826461392
Market cap (USD): 781166279.3266426
Debt to equity: 1.049103164326085
Current ratio: 1.6683961169607535
Quick ratio: 0.5061094504925586
Effective tax rate (%): 23.596487545747006
Interest coverage ratio: 4.584945247847529
COGS to revenue (%): 49.45130233009659
Buyback yield (%): 0
Retained earnings: 32216880.991349075
Inventory turnover: 0.2091363057778411
Receivables turnover: 2.288508004663407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.761105678755792
Revenue growth (%): 11.606574994479026
Rule of 40 score: 11.606574994479026
Financial ratios for MANORAMA.NS — annual report dated 2025-03-31
Total revenue: 90114788.40308627
Gross profit: 43624772.03647416
Operating income: 19203530.512041148
Net income: 12834872.574234275
Capital expenditures: 3703168.1084872573
Operating cash flow: -6651554.828150572
Depreciation & amortization: 2587549.684358195
Net tangible assets: 53474772.03647416
Owner earnings: 11719254.150105212
Return on net tangible assets (%): 21.91548220553745
Capex to operating income (%): 19.28378797932634
Buffett classification: The Great
Stock price: 12.375423036527017
P/E ratio: 60.86279975188977
Shares outstanding: 63122390
Book value: 53743500.11690437
P/B ratio: 14.535083826461392
Market cap (USD): 781166279.3266426
Debt to equity: 1.049103164326085
Current ratio: 1.6683961169607535
Quick ratio: 0.5061094504925586
Effective tax rate (%): 24.844952219271104
Interest coverage ratio: 4.191832068470989
COGS to revenue (%): 51.5897747644491
R&D to revenue (%): 0.2809006619904808
SG&A to revenue (%): 5.281108875892708
Free cash flow (dilution-adjusted): -12166541.968669627
Buyback yield (%): 0
Retained earnings: 32216880.991349075
Inventory turnover: 0.7224151546094169
Receivables turnover: 7.577465245625108
Capitalized R&D asset: 462206.5786363374
ROCI (R&D-adjusted, %): 32.033645472416225
Rosenberg metric: 89.63919616945529
FCF margin (%): -13.501160224943662
Revenue growth (%): 64.88283822660749
Rule of 40 score: 51.38167800166383
Financial ratios for MANORAMA.NS — quarterly report dated 2025-06-30
Total revenue: 33881441.61010999
Gross profit: 16052609.407910135
Operating income: 8071448.630938452
Net income: 5493201.497776738
Capital expenditures: 0
Depreciation & amortization: 669997.6597238474
Owner earnings: 6163199.157500586
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.08378188626258
P/E ratio: 78.56741472183964
Shares outstanding: 63122390
Market cap (USD): 1078369142.8996024
Effective tax rate (%): 28.318766490765167
Interest coverage ratio: 7.4563398551507944
COGS to revenue (%): 52.62123261272289
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 24.49082090432493
Rule of 40 score: 24.49082090432493
Financial ratios for MANORAMA.NS — quarterly report dated 2025-12-31
Total revenue: 40385195.49961012
Gross profit: 19329397.34878022
Operating income: 10884827.893505625
Net income: 8050740.781998441
Capital expenditures: 0
Depreciation & amortization: 715428.3168096247
Owner earnings: 8766169.098808065
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.873565779213546
P/E ratio: 43.113931768680075
Shares outstanding: 63122390
Market cap (USD): 938855019.8061714
Effective tax rate (%): 24.629805180381005
Interest coverage ratio: 7.280232757400329
COGS to revenue (%): 52.1374179085828
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 19.195623268755632
Rule of 40 score: 19.195623268755632
Financial ratios for MCY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.46
Shares outstanding: 55388627
Market cap (USD): 2573355610.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCY — annual report dated 2022-12-31
Total revenue: 3643066000
Net income: -512672000
Capital expenditures: 35505000
Operating cash flow: 352589000
Depreciation & amortization: 82390000
Net tangible assets: 1470123000
Owner earnings: -465787000
Return on net tangible assets (%): -31.683539404526016
Buffett classification: The Gruesome
Stock price: 31.31
Shares outstanding: 55388627
Book value: 1522131000
P/B ratio: 1.1393355180138898
Market cap (USD): 1734217911.37
Debt to equity: 0.2760958156689536
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 317081000
Buyback yield (%): 0
Retained earnings: 1423184000
Receivables turnover: 5.532378940590647
Capitalized R&D asset: 0
FCF margin (%): 8.703685302434817
Rule of 40 score: 8.703685302434817
Financial ratios for MCY — annual report dated 2023-12-31
Total revenue: 4629631000
Net income: 96336000
Capital expenditures: 6950000
Operating cash flow: 453004000
Depreciation & amortization: 72240000
Net tangible assets: 1497016000
Owner earnings: 161626000
Return on net tangible assets (%): 10.796544592709765
Buffett classification: The Gruesome
Stock price: 35.57
P/E ratio: 20.45106151791646
Shares outstanding: 55388627
Book value: 1548145000
P/B ratio: 1.2726026711903602
Market cap (USD): 1970173462.39
Debt to equity: 0.37978354740673514
Effective tax rate (%): 3.1097879872872833
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 416194000
Buyback yield (%): 0
Retained earnings: 1449198000
Receivables turnover: 6.979104734109589
Capitalized R&D asset: 0
FCF margin (%): 8.98978773902283
Revenue growth (%): 27.08062384815427
Rule of 40 score: 36.070411587177105
Financial ratios for MCY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.15
Shares outstanding: 55388627
Market cap (USD): 3387014541.0499997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCY — annual report dated 2024-12-31
Total revenue: 5475633000
Net income: 467953000
Capital expenditures: 33431000
Operating cash flow: 1037117000
Depreciation & amortization: 73433000
Net tangible assets: 1896046000
Owner earnings: 507955000
Return on net tangible assets (%): 26.790225553599438
Buffett classification: The Gruesome
Stock price: 64.83
P/E ratio: 7.673515691554493
Shares outstanding: 55388627
Book value: 1946524000
P/B ratio: 1.844747194696803
Market cap (USD): 3590844688.41
Debt to equity: 0.30192692204154686
Effective tax rate (%): 18.599881714444756
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 990979000
Buyback yield (%): 0
Retained earnings: 1846825000
Receivables turnover: 7.006505379990198
Capitalized R&D asset: 0
FCF margin (%): 18.09798063529824
Revenue growth (%): 18.273637791003214
Rule of 40 score: 36.37161842630145
Financial ratios for MCY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 64.83
Shares outstanding: 55388627
Market cap (USD): 3590844688.41
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCY — quarterly report dated 2025-03-31
Total revenue: 1393879000
Net income: -108327000
Capital expenditures: 13143000
Operating cash flow: -68729000
Depreciation & amortization: 17244000
Net tangible assets: 1770347000
Owner earnings: -104226000
Return on net tangible assets (%): -5.887320395380115
Buffett classification: The Gruesome
Stock price: 54.83
Shares outstanding: 55388627
Book value: 1820611000
P/B ratio: 1.6680984671684396
Market cap (USD): 3036958418.41
Debt to equity: 0.3252127994393091
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -81872000
Buyback yield (%): 0
Retained earnings: 1720912000
Receivables turnover: 0.9143487815277641
Capitalized R&D asset: 0
FCF margin (%): -5.873680570551676
Rule of 40 score: -5.873680570551676
Financial ratios for MCY — quarterly report dated 2025-06-30
Total revenue: 1477885000
Net income: 166472000
Capital expenditures: 1637000
Operating cash flow: 371605000
Depreciation & amortization: 17702000
Net tangible assets: 1919447000
Owner earnings: 182537000
Return on net tangible assets (%): 9.509874458633137
Buffett classification: The Gruesome
Stock price: 66.38
P/E ratio: 63.23324551139393
Shares outstanding: 55388627
Book value: 1969497000
P/B ratio: 1.8668203405539585
Market cap (USD): 3676697060.2599998
Debt to equity: 0.29966077633020005
Effective tax rate (%): 19.480720490645616
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 357235000
Buyback yield (%): 0
Retained earnings: 1869798000
Receivables turnover: 1.1931012713410598
Capitalized R&D asset: 0
FCF margin (%): 24.172043156267232
Revenue growth (%): 6.026778508034054
Rule of 40 score: 30.198821664301285
Financial ratios for MCY — quarterly report dated 2025-09-30
Total revenue: 1584926000
Net income: 280403000
Capital expenditures: 4517000
Operating cash flow: 496439000
Depreciation & amortization: 18774000
Net tangible assets: 2182478000
Owner earnings: 294660000
Return on net tangible assets (%): 13.501167022073075
Buffett classification: The Gruesome
Stock price: 83.91
P/E ratio: 13.728214881109915
Shares outstanding: 55388627
Book value: 2232314000
P/B ratio: 2.0819919113395335
Market cap (USD): 4647659691.57
Debt to equity: 0.2634660715293637
Effective tax rate (%): 19.957581397473152
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 479536000
Buyback yield (%): 0
Retained earnings: 2132615000
Receivables turnover: 1.5727841066963044
Capitalized R&D asset: 0
FCF margin (%): 30.256049809265544
Revenue growth (%): 7.2428504247624135
Rule of 40 score: 37.49890023402796
Financial ratios for MCY — quarterly report dated 2025-12-31
Total revenue: 1535779000
Net income: 202547000
Capital expenditures: 14015000
Operating cash flow: 287873000
Depreciation & amortization: 21269000
Net tangible assets: 2367652000
Owner earnings: 209801000
Return on net tangible assets (%): 8.861141755629628
Buffett classification: The Gruesome
Stock price: 93.43
P/E ratio: 9.563864793816244
Shares outstanding: 55388627
Book value: 2417275000
P/B ratio: 2.1408236218924204
Market cap (USD): 5174959420.610001
Debt to equity: 0.24277543928597284
Effective tax rate (%): 18.616275378798534
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 273858000
Buyback yield (%): 0
Retained earnings: 2317576000
Receivables turnover: 1.6307991428577497
Capitalized R&D asset: 0
FCF margin (%): 17.83186252709537
Revenue growth (%): -3.100901871759312
Rule of 40 score: 14.730960655336059
Financial ratios for MCY — annual report dated 2025-12-31
Total revenue: 5992468000
Net income: 541094000
Capital expenditures: 24278000
Operating cash flow: 1087188000
Depreciation & amortization: 74989000
Net tangible assets: 2367652000
Owner earnings: 591805000
Return on net tangible assets (%): 24.995438518836384
Buffett classification: The Gruesome
Stock price: 93.43
P/E ratio: 9.563882468868627
Shares outstanding: 55388627
Book value: 2417275000
P/B ratio: 2.1408236218924204
Market cap (USD): 5174959420.610001
Debt to equity: 0.24277543928597284
Effective tax rate (%): 18.466840151947792
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 1028757000
Buyback yield (%): 0
Retained earnings: 2317576000
Receivables turnover: 6.363227832912479
Capitalized R&D asset: 0
FCF margin (%): 17.167500936175212
Revenue growth (%): 9.438817393349773
Rule of 40 score: 26.606318329524985
Financial ratios for MEDICO.NS — annual report dated 2023-03-31
Total revenue: 16869439.70767357
Gross profit: 3138928.1364190015
Operating income: 840365.408038977
Net income: 882034.1047503046
Capital expenditures: 802411.6930572473
Operating cash flow: 994786.8453105969
Depreciation & amortization: 662728.3800243606
Net tangible assets: 5331668.696711328
Owner earnings: 742350.7917174179
Return on net tangible assets (%): 13.923423114705413
Capex to operating income (%): 95.4836652462533
Buffett classification: The Gruesome
Stock price: 0.9141291108404385
P/E ratio: 86.00357936891527
Shares outstanding: 82984000
Book value: 5340194.884287454
P/B ratio: 14.20511643819994
Market cap (USD): 75858090.13398294
Debt to equity: 0.2226489975594736
Current ratio: 1.545113717979411
Quick ratio: 1.0735144840794828
Effective tax rate (%): 28.29417065224925
Interest coverage ratio: 11.887319090282563
COGS to revenue (%): 81.39281333101322
SG&A to revenue (%): 8.898533626093066
Free cash flow (dilution-adjusted): 191827.0401948843
Buyback yield (%): 0
Retained earnings: 2913045.066991474
Inventory turnover: 5.7225857543898835
Receivables turnover: 3.837054542331465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.104327437754911
FCF margin (%): 1.1371275129406107
Rule of 40 score: 1.1371275129406107
Financial ratios for MEDICO.NS — annual report dated 2024-03-31
Total revenue: 17185549.82611824
Gross profit: 2963664.7079985607
Operating income: 1202794.1000119918
Net income: 994231.9222928409
Capital expenditures: 296234.5604988608
Operating cash flow: 292349.20254227123
Depreciation & amortization: 345293.20062357595
Net tangible assets: 6265787.264660032
Owner earnings: 1043290.562417556
Return on net tangible assets (%): 16.650590234715903
Capex to operating income (%): 24.628867109998907
Buffett classification: The Great
Stock price: 0.5770153550863724
P/E ratio: 48.16083768067151
Shares outstanding: 82984000
Book value: 6280237.438541792
P/B ratio: 7.624399984088099
Market cap (USD): 47883042.226487525
Debt to equity: 0.1537208640676406
Current ratio: 1.7216934528884043
Quick ratio: 1.340110663960406
Effective tax rate (%): 26.855111205215753
Interest coverage ratio: 15.611050583657587
COGS to revenue (%): 82.75490317164922
SG&A to revenue (%): 4.72261937906766
Free cash flow (dilution-adjusted): -4844.705600191869
Buyback yield (%): 0
Retained earnings: 3862213.6946876124
Inventory turnover: 7.259279435888647
Receivables turnover: 2.887399512421171
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.789644255446696
FCF margin (%): -0.028190576671739572
Revenue growth (%): 1.8738625818193466
Rule of 40 score: 1.845672005147607
Financial ratios for MEDICO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 6619541.32823698
Buffett classification: The Gruesome
Stock price: 0.6091734352603918
Shares outstanding: 82984000
Book value: 6630231.724796942
P/B ratio: 7.624416528699311
Market cap (USD): 50551648.35164835
Debt to equity: 0.205569257210183
Current ratio: 1.8037211371832698
Quick ratio: 1.4043627933117884
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDICO.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6405175428371604
Shares outstanding: 82984000
Market cap (USD): 53152707.77479892
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDICO.NS — quarterly report dated 2025-03-31
Total revenue: 4828536.357259762
Gross profit: 1629518.353986439
Operating income: 689700.7248071077
Net income: 507481.87982230535
Capital expenditures: 0
Depreciation & amortization: 89501.9873743278
Net tangible assets: 7295148.4685527235
Owner earnings: 596983.8671966331
Return on net tangible assets (%): 8.18329976106803
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6018205158128136
P/E ratio: 24.60258960462663
Shares outstanding: 82984000
Book value: 7302887.537993921
P/B ratio: 6.838592738062249
Market cap (USD): 49941473.684210524
Debt to equity: 0.23531069059964235
Current ratio: 1.6972007408512766
Quick ratio: 1.227999613774216
Effective tax rate (%): 23.82473195641111
Interest coverage ratio: 11.942712550607286
COGS to revenue (%): 66.25233334866705
Buyback yield (%): 0
Retained earnings: 4945090.016366612
Inventory turnover: 1.023871527777778
Receivables turnover: 0.7223293873632187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.388775545929361
Rule of 40 score: 0
Financial ratios for MEDICO.NS — annual report dated 2025-03-31
Total revenue: 17645616.08604162
Gross profit: 4981412.20481646
Operating income: 1399672.667757774
Net income: 1179939.2097264437
Capital expenditures: 372141.6880991349
Operating cash flow: 571907.8793546879
Depreciation & amortization: 354231.93827449146
Net tangible assets: 7295148.4685527235
Owner earnings: 1162029.4599018001
Return on net tangible assets (%): 15.928797952652687
Capex to operating income (%): 26.587765602031272
Buffett classification: The Good
Stock price: 0.6018205158128136
P/E ratio: 42.32546327178069
Shares outstanding: 82984000
Book value: 7302887.537993921
P/B ratio: 6.838592738062249
Market cap (USD): 49941473.684210524
Debt to equity: 0.23531069059964235
Current ratio: 1.6972007408512766
Quick ratio: 1.227999613774216
Effective tax rate (%): 25.256040936928397
Interest coverage ratio: 10.334743202416917
COGS to revenue (%): 71.7696895334986
SG&A to revenue (%): 7.072782273291613
Free cash flow (dilution-adjusted): 199298.57376665887
Buyback yield (%): 0
Retained earnings: 4945090.016366612
Inventory turnover: 4.053280651340996
Receivables turnover: 2.639712350495884
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.053499645118066
FCF margin (%): 1.12945092307835
Revenue growth (%): 2.677052899548089
Rule of 40 score: 3.806503822626439
Financial ratios for MEDICO.NS — quarterly report dated 2025-06-30
Total revenue: 4475953.662532179
Gross profit: 1276959.9812777909
Operating income: 240697.40229347066
Net income: 212766.20641235667
Capital expenditures: 0
Depreciation & amortization: 89983.6180669319
Owner earnings: 302749.82447928854
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4866604259302598
P/E ratio: 56.070997698199996
Shares outstanding: 82984000
Market cap (USD): 40385028.78539668
Effective tax rate (%): 25.297839125790816
Interest coverage ratio: 7.317680540732835
COGS to revenue (%): 71.47066128125695
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.302061507675521
Rule of 40 score: -7.302061507675521
Financial ratios for MEDICO.NS — quarterly report dated 2025-09-30
Total revenue: 5934069.8985343855
Gross profit: 1374396.8432919953
Operating income: 223731.6798196167
Net income: 289537.7677564825
Capital expenditures: 0
Depreciation & amortization: 82705.74971815107
Net tangible assets: 7531724.915445321
Owner earnings: 372243.5174746336
Return on net tangible assets (%): 4.942340853570915
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5435174746335963
P/E ratio: 44.66615761819723
Shares outstanding: 82984000
Book value: 7537497.18151071
P/B ratio: 5.983850212989997
Market cap (USD): 45103254.11499436
Debt to equity: 0.18737136840089982
Current ratio: 1.6163152721673966
Quick ratio: 1.0285476072790078
Effective tax rate (%): 26.075818197518785
Interest coverage ratio: 8.441088898341132
COGS to revenue (%): 76.83888348481625
Buyback yield (%): 0
Inventory turnover: 0.9773427512994813
Receivables turnover: 0.9173859088944352
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.96407708840851
Revenue growth (%): 32.576660661346246
Rule of 40 score: 32.576660661346246
Financial ratios for MEDICO.NS — quarterly report dated 2025-12-31
Total revenue: 6537027.960343099
Gross profit: 1623560.2094240838
Operating income: 394541.60632728087
Net income: 319962.1254316587
Capital expenditures: 0
Depreciation & amortization: 88024.95265678958
Owner earnings: 407987.07808844827
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5636626935501838
P/E ratio: 35.17582706301372
Shares outstanding: 82984000
Market cap (USD): 46774984.96156845
Effective tax rate (%): 25.050230931816404
Interest coverage ratio: 9.168521874191045
COGS to revenue (%): 75.1636336990844
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 10.160953142086077
Rule of 40 score: 10.160953142086077
Financial ratios for MINDACORP.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.688118159039958
Shares outstanding: 235360911
Market cap (USD): 632677938.7872874
Buyback yield (%): 0
Retained earnings: 86627983.64763287
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MINDACORP.NS — annual report dated 2023-03-31
Total revenue: 514969549.3300853
Gross profit: 164275274.05602923
Operating income: 40158343.48355664
Net income: 34652862.36297199
Capital expenditures: 30304506.699147385
Operating cash flow: 47186358.0998782
Depreciation & amortization: 16820950.06090134
Net tangible assets: 174129110.84043851
Owner earnings: 21169305.72472595
Return on net tangible assets (%): 12.157246782316735
Capex to operating income (%): 75.46254170457992
Buffett classification: The Gruesome
Stock price: 2.5959805115712546
P/E ratio: 17.63179998644288
Shares outstanding: 235360911
Book value: 193763702.8014616
P/B ratio: 3.153285828603847
Market cap (USD): 610992338.1416565
Debt to equity: 0.4482650238873524
Current ratio: 1.2478524706438647
Quick ratio: 0.7960438174797068
Effective tax rate (%): 1.373534338358459
Interest coverage ratio: 8.862903225806452
COGS to revenue (%): 68.10000236524043
SG&A to revenue (%): 2.667991201305613
Free cash flow (dilution-adjusted): 16272838.002436055
Buyback yield (%): 0
Retained earnings: 111607795.37149818
Inventory turnover: 5.02215245072388
Receivables turnover: 6.596816976127321
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.861000306842595
FCF margin (%): 3.1599612100570025
Rule of 40 score: 3.1599612100570025
Financial ratios for MINDACORP.NS — annual report dated 2024-03-31
Total revenue: 549238517.8078907
Gross profit: 183751049.2864852
Operating income: 43734260.70272215
Net income: 27245473.07830675
Capital expenditures: 30099532.318023745
Operating cash flow: 34392613.02314426
Depreciation & amortization: 19882479.913658712
Net tangible assets: 218059719.39081424
Owner earnings: 17028420.673941713
Return on net tangible assets (%): 7.809062912450503
Capex to operating income (%): 68.82369070468879
Buffett classification: The Good
Stock price: 4.983085412667946
P/E ratio: 43.046546446284985
Shares outstanding: 235360911
Book value: 237510492.86485192
P/B ratio: 4.937986141874153
Market cap (USD): 1172823522.3163388
Debt to equity: 0.27022114510754314
Current ratio: 1.7956277213352685
Quick ratio: 1.3175798258345428
Effective tax rate (%): 26.977950713359277
Interest coverage ratio: 6.741219963031424
COGS to revenue (%): 66.54439859391717
SG&A to revenue (%): 2.803432239470754
Free cash flow (dilution-adjusted): 4293080.705120518
Buyback yield (%): 0
Retained earnings: 156553543.59035856
Inventory turnover: 5.783301707779886
Receivables turnover: 5.69380905022377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.608148591971238
FCF margin (%): 0.7816423222200388
Revenue growth (%): 6.654562104183688
Rule of 40 score: 7.436204426403727
Financial ratios for MINDACORP.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 230765647.3960822
Buffett classification: The Gruesome
Stock price: 7.16292403248925
Shares outstanding: 235360911
Book value: 251108456.76063067
P/B ratio: 6.713721821473829
Market cap (USD): 1685872325.7104635
Debt to equity: 0.2538672298647183
Current ratio: 1.7009240658899158
Quick ratio: 1.2635596625150665
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MINDACORP.NS — quarterly report dated 2024-12-31
Total revenue: 146003030.65625364
Gross profit: 56086956.521739125
Operating income: 10863737.032288145
Net income: 7553327.893693903
Capital expenditures: 0
Depreciation & amortization: 5870148.03590162
Owner earnings: 13423475.929595523
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.684228931110852
P/E ratio: 44.279995466493055
Shares outstanding: 235360911
Market cap (USD): 1337845299.5588062
Effective tax rate (%): 28.797433344396506
Interest coverage ratio: 7.831932773109245
COGS to revenue (%): 61.58507376892125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MINDACORP.NS — annual report dated 2025-03-31
Total revenue: 591094224.9240121
Gross profit: 223258124.85386953
Operating income: 43311900.86509235
Net income: 29853869.534720596
Capital expenditures: 39991816.69394435
Operating cash flow: 63635725.9761515
Depreciation & amortization: 23884732.288987607
Net tangible assets: 236310498.01262566
Owner earnings: 13746785.129763857
Return on net tangible assets (%): 5.817255367567034
Capex to operating income (%): 92.33447596426355
Buffett classification: The Gruesome
Stock price: 6.275761465748629
P/E ratio: 49.47663263817223
Shares outstanding: 235360911
Book value: 257446808.51063824
P/B ratio: 5.737375205163039
Market cap (USD): 1477068935.7972927
Debt to equity: 0.7308600490418674
Current ratio: 0.8550244598450877
Quick ratio: 0.5590603342845495
Effective tax rate (%): 28.737412858249417
Interest coverage ratio: 5.509964306960143
COGS to revenue (%): 62.22968937269343
SG&A to revenue (%): 3.1485971733824876
Free cash flow (dilution-adjusted): 22696983.86719663
Buyback yield (%): 0
Retained earnings: 178653261.631985
Inventory turnover: 5.417475895316803
Receivables turnover: 6.110235649546827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.684972780497827
FCF margin (%): 3.8398250076143845
Revenue growth (%): 7.620679496983394
Rule of 40 score: 11.460504504597779
Financial ratios for MINDACORP.NS — quarterly report dated 2025-03-31
Total revenue: 154461070.84404954
Gross profit: 59104512.50876782
Operating income: 11231003.039513677
Net income: 6082534.486789806
Capital expenditures: 0
Depreciation & amortization: 6641337.386018236
Net tangible assets: 236310498.01262566
Owner earnings: 12723871.872808043
Return on net tangible assets (%): 5.384387058474325
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.275761465748629
P/E ratio: 60.7094353104461
Shares outstanding: 235360911
Book value: 257446808.51063824
P/B ratio: 5.737375205163039
Market cap (USD): 1477068935.7972927
Debt to equity: 0.7308600490418674
Current ratio: 0.8550244598450877
Quick ratio: 0.5590603342845495
Effective tax rate (%): 35.70107858243452
Interest coverage ratio: 2.7846376811594205
COGS to revenue (%): 61.73501052026097
Buyback yield (%): 0
Retained earnings: 178653261.631985
Inventory turnover: 1.4044077134986226
Receivables turnover: 1.596688821752266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.289279967131167
Revenue growth (%): 5.79305795898808
Rule of 40 score: 5.79305795898808
Financial ratios for MINDACORP.NS — quarterly report dated 2025-06-30
Total revenue: 162167095.71729466
Gross profit: 61288322.0219986
Operating income: 11729464.07676106
Net income: 7642171.776269601
Capital expenditures: 0
Depreciation & amortization: 6558623.91762228
Owner earnings: 14200795.693891881
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.084952024338873
P/E ratio: 67.30696272452155
Shares outstanding: 235360911
Market cap (USD): 1432159851.8396912
Effective tax rate (%): 26.240633394599183
Interest coverage ratio: 3.05609756097561
COGS to revenue (%): 62.20668456143389
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.988975429948592
Rule of 40 score: 4.988975429948592
Financial ratios for MINDACORP.NS — quarterly report dated 2025-12-31
Total revenue: 173809735.9919795
Gross profit: 64622925.25342543
Operating income: 14014704.244179571
Net income: 9546619.137796592
Capital expenditures: 0
Depreciation & amortization: 6428650.996992314
Owner earnings: 15975270.134788906
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.388771304444692
P/E ratio: 48.78131215349709
Shares outstanding: 235360911
Market cap (USD): 1503667034.384761
Effective tax rate (%): 32.72896808951513
Interest coverage ratio: 4.405112044817927
COGS to revenue (%): 62.81973222926508
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.179409745970553
Rule of 40 score: 7.179409745970553
Financial ratios for MKC — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.93
Shares outstanding: 254055150
Market cap (USD): 19544462689.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKC — annual report dated 2022-11-30
Total revenue: 6350500000
Gross profit: 2274500000
Operating income: 917400000
Net income: 682000000
Capital expenditures: 262000000
Operating cash flow: 651500000
Depreciation & amortization: 200600000
Net tangible assets: -4080900000
Owner earnings: 620600000
Return on net tangible assets (%): -15.207429733637188
Capex to operating income (%): 28.558971005014172
Buffett classification: The Good
Stock price: 77.67
P/E ratio: 28.93323093914956
Shares outstanding: 254055150
Book value: 4699200000
P/B ratio: 4.199111231805413
Market cap (USD): 19732463500.5
Debt to equity: 1.1333205652025877
Current ratio: 0.6953443654585713
Quick ratio: 0.30491784174338654
Effective tax rate (%): 20.74311023622047
Interest coverage ratio: 6.152917505030181
COGS to revenue (%): 64.18392252578538
SG&A to revenue (%): 21.369970868435555
Free cash flow (dilution-adjusted): 329200000
Buyback yield (%): 0.19663028896020432
Retained earnings: 3022500000
Inventory turnover: 3.0415640623834044
Receivables turnover: 11.06937423740631
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.465050296621099
FCF margin (%): 5.183843791827416
Rule of 40 score: 5.183843791827416
Financial ratios for MKC — annual report dated 2023-11-30
Total revenue: 6662200000
Gross profit: 2502500000
Operating income: 1024200000
Net income: 680600000
Capital expenditures: 263900000
Operating cash flow: 1237300000
Depreciation & amortization: 199300000
Net tangible assets: -3716000000
Owner earnings: 616000000
Return on net tangible assets (%): -16.576964477933263
Capex to operating income (%): 25.76645186487014
Buffett classification: The Good
Stock price: 60.3
P/E ratio: 22.508853283867175
Shares outstanding: 254055150
Book value: 5083500000
P/B ratio: 3.0135783505458837
Market cap (USD): 15319525545
Debt to equity: 0.9031769450181961
Current ratio: 0.6459066120236213
Quick ratio: 0.2823905256703992
Effective tax rate (%): 21.848003004882933
Interest coverage ratio: 4.9193083573487035
COGS to revenue (%): 62.43733301311879
SG&A to revenue (%): 22.18936687580679
Free cash flow (dilution-adjusted): 910000000
Buyback yield (%): 0.23303593766748082
Retained earnings: 3249700000
Inventory turnover: 3.6925876608965824
Receivables turnover: 11.33991489361702
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.49019808673208
FCF margin (%): 13.659151631593167
Revenue growth (%): 4.908274938981182
Rule of 40 score: 18.567426570574348
Financial ratios for MKC — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.76
Shares outstanding: 254055150
Market cap (USD): 19247218164
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKC — annual report dated 2024-11-30
Total revenue: 6723700000
Gross profit: 2591000000
Operating income: 1069800000
Net income: 788500000
Capital expenditures: 274900000
Operating cash flow: 921900000
Depreciation & amortization: 208800000
Net tangible assets: -3434500000
Owner earnings: 722400000
Return on net tangible assets (%): -21.033629349250255
Capex to operating income (%): 25.69639184894373
Buffett classification: The Good
Stock price: 74.62
P/E ratio: 24.042606585922638
Shares outstanding: 254055150
Book value: 5316800000
P/B ratio: 3.5656024851414387
Market cap (USD): 18957595293
Debt to equity: 0.8479724646403852
Current ratio: 0.7419869571250174
Quick ratio: 0.31188427917302625
Effective tax rate (%): 20.48313481019704
Interest coverage ratio: 5.108882521489972
COGS to revenue (%): 61.464669750286305
SG&A to revenue (%): 22.624447848654757
Free cash flow (dilution-adjusted): 599600000
Buyback yield (%): 0.2800988162227881
Retained earnings: 3545000000
Inventory turnover: 3.3330913783369627
Receivables turnover: 11.446544092611509
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.501104294478528
FCF margin (%): 8.917708999509198
Revenue growth (%): 0.92311848938789
Rule of 40 score: 9.840827488897089
Financial ratios for MKC — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.62
Shares outstanding: 254055150
Market cap (USD): 18957595293
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MKC — quarterly report dated 2025-02-28
Total revenue: 1605500000
Gross profit: 604000000
Operating income: 225200000
Net income: 163400000
Capital expenditures: 37100000
Operating cash flow: 115500000
Depreciation & amortization: 53800000
Net tangible assets: -3091200000
Owner earnings: 180100000
Return on net tangible assets (%): -5.826216356107661
Capex to operating income (%): 16.47424511545293
Buffett classification: The Great
Stock price: 79.08
P/E ratio: 30.738496422888616
Shares outstanding: 254055150
Book value: 5449700000
P/B ratio: 3.6865664645760314
Market cap (USD): 20090681262
Debt to equity: 0.7904471805787474
Current ratio: 0.6488603758986428
Quick ratio: 0.2473000419097972
Effective tax rate (%): 22.30563002680965
Interest coverage ratio: 4.643298969072165
COGS to revenue (%): 62.37932108377453
SG&A to revenue (%): 23.59389598255995
Free cash flow (dilution-adjusted): 58400000
Buyback yield (%): 0.08561183055814288
Retained earnings: 3694300000
Inventory turnover: 0.8040301862556197
Receivables turnover: 3.1060166376475142
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2984517090396923
FCF margin (%): 3.6374961071317347
Rule of 40 score: 3.6374961071317347